Key result
Diabetic hyperglycemia drives vascular CaV1.2 superclustering and hypercontractility via PKA-dependent phosphorylation.
Why the study?
Mechanisms regulating L-type CaV1.2 channel cooperative gating are unclear, and whether α1C phosphorylation at S1928 mediates vascular CaV1.2 cooperativity during diabetic hyperglycemia was unknown.
Does diabetic hyperglycemia increase CaV1.2 cooperativity and alter vascular reactivity in human and mouse arterial myocytes?
Does diabetic hyperglycemia increase CaV1.2 cooperativity and alter vascular reactivity in human and mouse arterial myocytes?
Identifying S1928 phosphorylation as a necessary step for vascular CaV1.2 hyperactivation in diabetes offers a potential mechanism-specific therapeutic target.
May identify S1928 as a diabetic vascular target; leaves open human translation and therapeutic validation.
Background: L-type Ca V 1.2 channels undergo cooperative gating to regulate cell function, although mechanisms are unclear. This study tests the hypothesis that phosphorylation of the Ca V 1.2 pore-forming subunit α1 C at S1928 mediates vascular Ca V 1.2 cooperativity during diabetic hyperglycemia. Methods: A multiscale approach including patch-clamp electrophysiology, super-resolution nanoscopy, proximity ligation assay, calcium imaging‚ pressure myography, and Laser Speckle imaging was implemented to examine Ca V 1.2 cooperativity, α1 C clustering, myogenic tone, and blood flow in human and mouse arterial myocytes/vessels. Results: Ca V 1.2 activity and cooperative gating increase in arterial myocytes from patients with type 2 diabetes and type 1 diabetic mice, and in wild-type mouse arterial myocytes after elevating extracellular glucose. These changes were prevented in wild-type cells pre-exposed to a PKA inhibitor or cells from knock-in S1928A but not S1700A mice. In addition, α1 C clustering at the surface membrane of wild-type, but not wild-type cells pre-exposed to PKA or P2Y 11 inhibitors and S1928A arterial myocytes, was elevated upon hyperglycemia and diabetes. Ca V 1.2 spatial and gating remodeling correlated with enhanced arterial myocyte Ca 2+ influx and contractility and in vivo reduction in arterial diameter and blood flow upon hyperglycemia and diabetes in wild-type but not S1928A cells/mice. Conclusions: These results suggest that PKA-dependent S1928 phosphorylation promotes the spatial reorganization of vascular α1 C into “superclusters” upon hyperglycemia and diabetes. This triggers Ca V 1.2 activity and cooperativity, directly impacting vascular reactivity. The results may lay the foundation for developing therapeutics to correct Ca V 1.2 and arterial function during diabetic hyperglycemia.
No takes yet. Share an insight, caveat, or question.
Baudel et al. (2022) studied Diabetic hyperglycemia and vascular dysfunction. Hyperglycemia and diabetic conditions vs. Normoglycemia and nondiabetic controls was evaluated on CaV1.2 channel activity, cooperativity, and spatial reorganization (clustering). Diabetic hyperglycemia triggered PKA-dependent S1928 phosphorylation and spatial reorganization of vascular alpha1C subunits into superclusters, increasing CaV1.2 cooperativity and contractility.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: